Queensland joins Victoria with agreement for mRNA research.
QLD VACCINE HUB
The Queensland government — one of the “world’s largest vaccine innovators” — and two Australian universities, have announced they will collectively commit $280 million towards establishing the ‘Translational Science Hub’.
This ‘science hub’ will be a biomedical research centre focused on developing mRNA technology.
The partnership, which will involve scientists from the University of Queensland and Griffith University, is expected to create roughly 200 jobs within the research and clinical trials ecosystem, including researchers and healthcare professionals dedicated to improving mRNA technology.
The Translational Science Hub will be located across the state, utilising laboratories and infrastructure of the University of Queensland, Griffith University and the Translational Research Institute (TRI).
Paris-based Sanofi will connect Australian scientists with researchers in France and the United States, who will together focus on developing a world-first mRNA vaccine for sexually transmissible infection (STI) chlamydia, as well as other mRNA vaccines.
“Queensland, Australia has some of the best researchers in the world, and the Translational Science Hub will give them the platform to develop life-saving medicines and vaccines,” Queensland Premier Annastacia Palaszczuk said.
“The Hub will bring more expertise, supply-chain capabilities, as well as clinical investigations to Queensland. We’re proud one of the world’s largest healthcare companies has chosen Queensland to help reshape 21st-century medicine.”
Sanofi operates 20 research and development sites around the world exploring new medicines and vaccines. The company, which has a team across roughly 100 countries, is also developing therapeutic mRNA technology to address challenges in cancer, immune-mediated diseases, and rare diseases.
In Australia, Sanofi is a major supplier of 17 vaccines with seven on the National Immunisation Program (NIP). The company has 50-plus medicines on the Pharmaceutical Benefits Scheme (PBS) and six rare disease therapies on the Life Saving Drugs Program.
Last month, its protein-based adjuvanted COVID-19 booster vaccine – developed alongside GSK and BARDA – was approved for use in Europe.
“New generation vaccines based on mRNA technology will be an important part of Australia’s vaccine toolkit,” Sanofi Australia and New Zealand Country Medical Lead Dr Iris Depaz said.
“mRNA vaccines will complement existing vaccine technology, while having the potential to tackle diseases for which there is unmet need. For example, chlamydia, for which there is no vaccine yet.”
Sanofi Australia and New Zealand Country Lead, Karen Hood, added that collaboration was absolutely critical when combatting disease.
“The Translational Science Hub shows we are proud to invest in Australia and work as partners to harness cutting-edge science to forge a new era in medical innovation,” Hood said.
“By linking our global expertise with the knowledge bank here in Australia, we will help nurture a science ecosystem that is expected to create research and industry jobs in Queensland.”
It is slated to commence by March 2023.
Australia is being praised as a world-leader in mRNA research and innovation.
AUSTRALIA: MRNA CENTRAL
During the pandemic period, medical researchers began lobbying the Morrison government to establish a home-grown facility to reduce the country’s reliance on offshore producers for vaccines.
In March 2022, Victoria became the first place in the southern hemisphere to ink an mRNA vaccine deal, thanks to an agreement between Moderna, the Victorian government and the Commonwealth.
“MRNA is the software of life,” said Moderna’s chief technical operations and quality officer, Juan Andres.
Australia is indeed investing heavily in this ‘software’.
At the beginning of November, Australia’s biotech manufacturing giant, CSL, signed a new $313 million deal to bring “next-generation” mRNA flu shots to our shores.
Perhaps this is the reason for the new facility in Brisbane?
Either way, mRNA vaccines are far from a pastime in Australia, with a range of ‘innovative’ vaccines set to soon be released on our shores and new human clinical trials announced.
Clinical trials for several COVID-19 vaccine candidates, including for CSL and Novavax, were actually conducted right here in Australia. The government claims our country is a “go-to destination” for trials.
It seems the term ‘natural immunity’ has been erased from the human vernacular at this point, with needles across every corner for every ailment, cold, pimple or sore.
All hail the vaccine gods!
Meanwhile, perhaps there is a deeper agenda at play here. One in relation to the QLD Premier and her father’s genetic data storage company.
Or maybe that’s just a ‘conspiracy theory’.
Nothing to see here, folks.
For more TOTT News:
Facebook — Facebook.com/TOTTNews
YouTube — YouTube.com/TOTTNews
Instagram — Instagram.com/TOTTNews
Twitter — Twitter.com/EthanTOTT
Bitchute — Bitchute.com/TOTTNews
Gab — Gab.com/TOTTNews